Tuesday, August 15, 2017 2:56:50 PM
jonblair77 Friday, 12/02/16 08:10:07 PM
Re: 4u2nv2 post# 190119
Post #
190120
of 193655 Go
There are a few holders/buyers who believe they will get the drug through trials and this is a $1+ stock. When the stock drops to trips they buy shares
for the run they believe will come.
Lots of the old holders did this prior to the stock going to a dime during the Bio harp run. Many of them made a huge amount of cash.
I won't buy anymore shares, but have been holding. That is why I say always say I am holding for boom or bust. This stock has done well for me in the past few runs. I don't know if it will again, but if you do research you can do the math to understand that if the drug gets through trials(long shot), this could easily be a $2 stock. For some the chance of retirement is worth the gamble to buy in the trips.
So 10M shares at 001 is 10K for the potential return in about a year after trials start is maybe 15 to 25 million, some of the holder/buyers here will say more than than that...,, so the risk vs reward here is "worth it" for them!
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM